Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
14.9%
1.05
1.56
0.73
12.28%
-20.7%
51.20
Nifty 500 benchmark
17.2%
0.35
0.47
—
—
-37.3%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
83 months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
355
-12.6%
18.0%
92.2%
20%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
How it behaves against its benchmark
Up capture
Down capture
Correlation
Tracking error
Information ratio
Treynor
102%
50%
0.72
13.7%
0.72
25.40
Up capture is how much of the benchmark's gain this scheme kept in the months the
benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it
on the up side is the combination every fund is trying for and few reach.
Measured over the 83 months this scheme and
Nifty 500 share.
ICICI Prudential Healthcare Fund
Regular Plan · Cumulative
Allocation
By asset
Equity
95.01%
Cash & Equivalents
4.99%
By market cap
Large Cap
22.89%
Mid Cap
29.96%
Small Cap
41.24%
Unclassified
0.92%
Concentration
Number of stocks
35
Top 5 stocks
36.42%
Top 10 stocks
57.44%
Top 20 stocks
79.33%
Lines in the filing
38
Largest holding
12.31%
Largest sector
Pharmaceuticals & Biotechnology 70.69%
Effective stocks
21.7
Sectors held
6
Cash
4.99%
Effective stocks is what the concentration works out to: a fund holding
35 names but most of its money in a few
behaves like a fund of 22. Cash includes repo and TREPS, which
every fund parks money in overnight.
Sector split
Pharmaceuticals & Biotechnology
70.69%
Healthcare Services
15.91%
Retailing
5.38%
Cash & Equivalents
4.99%
Chemicals & Petrochemicals
1.22%
Insurance
1.13%
Healthcare Equipment & Supplies
0.67%
ICICI Prudential Healthcare Fund
Regular Plan · Cumulative · holdings
Top 30 holdings
#
Company
Sector
Shares held
Value ₹ cr
% of fund
1
Sun Pharmaceutical Industries Ltd.
Pharmaceuticals & Biotechnology
4,338,091
861
12.31%
2
Dr. Reddy's Laboratories Ltd.
Pharmaceuticals & Biotechnology
5,008,009
578
8.26%
3
Cipla Ltd.
Pharmaceuticals & Biotechnology
2,857,946
403
5.76%
4
Mankind Pharma Ltd.
Pharmaceuticals & Biotechnology
1,507,093
365
5.21%
5
Alkem Laboratories Ltd.
Pharmaceuticals & Biotechnology
639,791
341
4.87%
6
Divi's Laboratories Ltd.
Pharmaceuticals & Biotechnology
356,579
338
4.83%
7
TREPS
Unclassified
—
334
4.78%
8
Biocon Ltd.
Pharmaceuticals & Biotechnology
7,943,167
327
4.68%
9
Medplus Health Services Ltd
Retailing
4,317,751
290
4.15%
10
Cohance Lifesciences Ltd.
Pharmaceuticals & Biotechnology
6,266,692
286
4.08%
11
Syngene International Ltd.
Healthcare Services
5,747,880
230
3.29%
12
Dr Agarwal's Health Care Ltd
Healthcare Services
3,800,000
195
2.79%
13
MAX Healthcare Institute Ltd
Healthcare Services
1,741,433
181
2.59%
14
Alembic Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
2,077,449
173
2.48%
15
Abbott India Ltd.
Pharmaceuticals & Biotechnology
64,361
166
2.38%
16
Akums Drugs and Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
1,795,770
139
1.99%
17
Astrazeneca Pharma India Ltd.
Pharmaceuticals & Biotechnology
199,762
139
1.99%
18
Lupin Ltd.
Pharmaceuticals & Biotechnology
626,941
137
1.96%
19
Blue Jet Healthcare Ltd.
Pharmaceuticals & Biotechnology
2,337,144
135
1.93%
20
Indegene Ltd.
Healthcare Services
2,191,275
134
1.92%
21
Pfizer Ltd.
Pharmaceuticals & Biotechnology
277,493
130
1.86%
22
Metropolis Healthcare Ltd.
Healthcare Services
2,091,796
122
1.74%
23
Rainbow Childrens Medicare Ltd
Healthcare Services
673,760
95
1.36%
24
Thyrocare Technologies Ltd.
Healthcare Services
1,500,766
91
1.30%
25
Entero Healthcare Solutions
Retailing
476,507
86
1.23%
26
Fine Organic Industries Ltd.
Chemicals & Petrochemicals
161,698
85
1.22%
27
Alivus Life Sciences Ltd.
Pharmaceuticals & Biotechnology
602,385
85
1.21%
28
Medi Assist Healthcare Services Ltd
Insurance
2,407,739
79
1.13%
29
Aarti Drugs Ltd.
Pharmaceuticals & Biotechnology
1,865,108
77
1.10%
30
Hikal Ltd.
Pharmaceuticals & Biotechnology
3,641,193
73
1.05%
ICICI Prudential Healthcare Fund
Regular Plan · Cumulative · where the money sits
A ₹10,000 monthly SIP over five years
Invested
Value
Gain
XIRR
₹600,000
₹974,856
₹374,856
19.50%
XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has
been invested for a different length of time.
Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 25 Sep 2026.
